Results for tag: "Urea Cycle Disorder"

The Urea Cycle Disorder (UCD) market is a subset of the Urology and Nephrology market. UCDs are a group of inherited metabolic disorders that affect the liver's ability to process nitrogen waste from the body. Symptoms of UCDs can include vomiting, lethargy, and mental confusion. Treatment for UCDs typically involves dietary changes, medications, and in some cases, liver transplantation. The UCD market is composed of a variety of products and services, including diagnostic tests, medications, and medical devices. Diagnostic tests are used to identify UCDs, while medications are used to manage symptoms and reduce the risk of complications. Medical devices, such as dialysis machines, are used to treat kidney failure caused by UCDs. The UCD market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Baxter, and Novartis. Show Less Read more